Booth 80
Cardiovascular, Renal and Metabolism (CVRM) together forms one of AstraZeneca’s three therapy areas and is a key growth driver for the Company. By following the science to understand more clearly the underlying links between the heart, kidneys and pancreas, AstraZeneca is investing in a portfolio of medicines to protect organs and improve outcomes by slowing disease progression, reducing risks and tackling comorbidities.
Product type: Pharmaceutical products
Booth 80

1 Francis Crick Avenue
Cambridge Biomedical Campus
CB2 0AA Cambridge
Phone: + 44 203 749 5000